Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis . Anthrax most commonly occurs in hoofed mammals and can also infect humans. Symptoms of disease vary depending on how the disease was contracted, but usually occur within 7 days after exposure. The serious forms of human anthrax are inhalation anthrax, cutaneous anthrax, and intestinal anthrax.
Initial symptoms of inhalation anthrax infection may resemble a common cold. After several days, the symptoms may progress to severe breathing problems and shock. Inhalation anthrax is often fatal.
The intestinal disease form of anthrax may follow the consumption of contaminated food and is characterized by an acute inflammation of the intestinal tract. Initial signs of nausea, loss of appetite, vomiting, and fever are followed by abdominal pain, vomiting of blood, and severe diarrhea.
Direct person-to-person spread of anthrax is extremely unlikely, if it occurs at all. Therefore, there is no need to immunize or treat contacts of persons ill with anthrax, such as household contacts, friends, or coworkers, unless they also were also exposed to the same source of infection.
In persons exposed to anthrax, infection can be prevented with antibiotic treatment.
Early antibiotic treatment of anthrax is essential - delay lessens chances for survival. Anthrax usually is susceptible to penicillin, doxycycline, and fluoroquinolones.
An anthrax vaccine also can prevent infection. Vaccination against anthrax is not recommended for the general public to prevent disease and is not available.
Additional Information for the General Public
- Anthrax Frequently Asked Questions
- Anthrax Signs and Symptoms
- How Is Anthrax Diagnosed?
- Anthrax and the Mail
- Anthrax Treatment
- Anthrax Vaccination
- Anthrax and Influenza
Additional Information for Health Care Providers
- Anthrax Diagnosis/Evaluation
- Clinical Issues in the Prophylaxis, Diagnosis, and Treatment of Anthrax
- Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthrax
- Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax
- Cutaneous Anthrax Management Algorithm